The report provides a detailed analysis essential for establishing a Clobetasol Propionate production plant. It encompasses all critical aspects necessary for Clobetasol Propionate production, including the cost of Clobetasol Propionate production, Clobetasol Propionate plant cost, Clobetasol Propionate production costs, and the overall Clobetasol Propionate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Clobetasol Propionate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Clobetasol Propionate is a corticosteroid mainly used to treat skin conditions that respond well to steroid therapy, such as plaque psoriasis, a chronic skin disorder characterized by the formation of thick, red patches covered in white scales, and corticosteroid-responsive dermatoses, which include a variety of inflammatory skin problems characterized by redness, swelling, and itching. Additionally, its ophthalmic suspension is recommended for the management of pain and inflammation following ocular surgery. Moreover, it is well known for having anti-inflammatory, vasoconstrictive, and anti-pruritic properties.
The market for Clobetasol Propionate is driven by its usage as a corticosteroid for the treatment of plaque psoriasis and corticosteroid-responsive dermatoses, which significantly promotes its demand in the pharmaceutical and medical industries. The widespread occurrence of skin conditions is significantly increasing the demand for Clobetasol Propionate. Additionally, its utilization as an ophthalmic suspension for the management of pain and inflammation following ocular surgery further amplifies its market presence.
Moreover, its availability in various formulations, such as ointments, creams, and sprays, contributes to its growing demand. Overall, industrial Clobetasol Propionate procurement is influenced by its usage in the pharmaceutical and medical industries, rising cases of skin conditions, its utilization for the management of pain and inflammation following ocular surgery, availability in various formulations, along with cost-effectiveness, advancements in healthcare facilities, and regulatory approvals.
Raw Material for Clobetasol Propionate Production
According to the Clobetasol Propionate production plant project report, the key raw material used in the production of Clobetasol Propionate includes betamethasone 17-propionate.
Production Process of Clobetasol Propionate
The extensive Clobetasol Propionate production cost report consists of the following major industrial production process:
- Production from betamethasone 17-propionate: The production synthesis of Clobetasol Propionate starts with the mesylation of betamethasone 17-propionate with methanesulfonyl chloride in the presence of pyridine to give an intermediate. The intermediate is finally refluxed in acetone, DMF, and dry LiCl mixture to produce Clobetasol Propionate.
Clobetasol Propionate, commercially known as Clobex, Clodan, or Dermovate, is a white to off-white crystalline powder having the molecular formula C25H32ClFO5 and a molecular weight of 467.0 g/mol. It has a melting point of around 196 °C. It dissolves in water to some extent, having an estimated water solubility of 0.00413 mg/mL. It is easily soluble in acetone and dichloromethane.
It has a log P value of 3.50. The value of its dissociation constant, pKa, is 13.63. It is a prednisolone derivative having a greater affinity for glucocorticoid receptors than mineralocorticoid receptors. It is the propionate salt form of Clobetasol. It works by attaching itself to glucocorticoid receptors in the cytoplasm, which then triggers the production of genes regulated by glucocorticoid receptors, which prevents the creation of some inflammatory mediators and causes the synthesis of some anti-inflammatory proteins.
